Centre Asset Management, LLC Johnson & Johnson Transaction History

Centre Asset Management, LLC

$389 Million
Q1 2025

A detailed history of Centre Asset Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Centre Asset Management, LLC holds 19,073 shares of JNJ stock, worth $3.16 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares

19,073

Previous 80,660 76.35%

Holding current value

$3.16 Million

Previous $11.7 Million 72.88%

% of portfolio

0.81%

Previous 2.67%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 01, 2025	SELL	$142.06 - $167.7 $8.75 Million - $10.3 Million	-61,587 Reduced 76.35%	19,073 $3.16 Million
Q4 2024 Jan 03, 2025	SELL	$143.34 - $165.86 $1.13 Million - $1.3 Million	-7,865 Reduced 8.88%	80,660 $11.7 Million
Q3 2024 Oct 15, 2024	BUY	$145.48 - $167.38 $89,615 - $103,106	616 Added 0.7%	88,525 $14.3 Million
Q2 2024 Jul 02, 2024	BUY	$144.38 - $157.78 $2.17 Million - $2.37 Million	15,037 Added 20.63%	87,909 $12.8 Million
Q1 2024 Apr 02, 2024	SELL	$155.22 - $162.74 $2.06 Million - $2.16 Million	-13,248 Reduced 15.38%	72,872 $11.5 Million
Q4 2023 Jan 08, 2024	BUY	$145.6 - $158.88 $8.21 Million - $8.96 Million	56,400 Added 189.77%	86,120 $13.5 Million
Q3 2023 Oct 12, 2023	SELL	$155.75 - $174.48 $161,045 - $180,412	-1,034 Reduced 3.36%	29,720 $4.63 Million
Q2 2023 Jul 06, 2023	BUY	$154.35 - $166.11 $125,332 - $134,881	812 Added 2.71%	30,754 $5.09 Million
Q1 2023 Apr 03, 2023	BUY	$151.05 - $180.26 $69,483 - $82,919	460 Added 1.56%	29,942 $4.64 Million
Q4 2022 Feb 07, 2023	BUY	$160.2 - $179.79 $253,276 - $284,247	1,581 Added 5.67%	29,482 $5.21 Million
Q3 2022 Oct 04, 2022	SELL	$161.33 - $179.52 $7,421 - $8,257	-46 Reduced 0.16%	27,901 $4.56 Million
Q2 2022 Jul 06, 2022	BUY	$168.19 - $186.01 $1.42 Million - $1.57 Million	8,423 Added 43.14%	27,947 $4.96 Million
Q1 2022 Apr 13, 2022	BUY	$158.14 - $179.59 $3.09 Million - $3.51 Million	19,524 New	19,524 $3.46 Million
Q3 2021 Nov 03, 2021	SELL	$161.5 - $179.47 $2.19 Million - $2.44 Million	-13,580 Closed	0 $0
Q2 2021 Jul 08, 2021	SELL	$159.48 - $171.07 $513,525 - $550,845	-3,220 Reduced 19.17%	13,580 $2.24 Million
Q1 2021 Apr 08, 2021	SELL	$153.07 - $170.48 $1.01 Million - $1.13 Million	-6,610 Reduced 28.24%	16,800 $2.76 Million
Q4 2020 Jan 19, 2021	BUY	$137.11 - $157.38 $608,768 - $698,767	4,440 Added 23.41%	23,410 $3.68 Million
Q3 2020 Oct 29, 2020	BUY	$140.38 - $153.83 $307,432 - $336,887	2,190 Added 13.05%	18,970 $2.82 Million
Q2 2020 Jul 13, 2020	SELL	$128.81 - $155.51 $1.37 Million - $1.65 Million	-10,610 Reduced 38.74%	16,780 $2.36 Million
Q1 2020 Apr 06, 2020	SELL	$111.14 - $153.99 $423,443 - $586,701	-3,810 Reduced 12.21%	27,390 $3.59 Million
Q4 2019 Jan 14, 2020	SELL	$127.5 - $146.44 $14.5 Million - $16.6 Million	-113,610 Reduced 78.45%	31,200 $4.55 Million
Q3 2019 Oct 21, 2019	BUY	$126.95 - $142.14 $11.5 Million - $12.9 Million	90,610 Added 167.18%	144,810 $18.7 Million
Q2 2019 Jul 15, 2019	BUY	$131.15 - $144.24 $493,124 - $542,342	3,760 Added 7.45%	54,200 $7.55 Million
Q1 2019 Apr 17, 2019	SELL	$125.72 - $139.79 $5.73 Million - $6.37 Million	-45,590 Reduced 47.47%	50,440 $7.05 Million
Q4 2018 Jan 14, 2019	BUY	$122.84 - $147.84 $5.91 Million - $7.12 Million	48,140 Added 100.52%	96,030 $12.4 Million
Q3 2018 Oct 03, 2018	SELL	$121.58 - $142.88 $300,302 - $352,913	-2,470 Reduced 4.9%	47,890 $6.62 Million
Q2 2018 Aug 06, 2018	SELL	$119.4 - $131.76 $423,870 - $467,747	-3,550 Reduced 6.59%	50,360 $6.11 Million
Q1 2018 Apr 25, 2018	SELL	$125.1 - $148.14 $545,436 - $645,890	-4,360 Reduced 7.48%	53,910 $6.91 Million
Q4 2017 Feb 13, 2018	SELL	$131.22 - $143.62 $4.23 Million - $4.63 Million	-32,250 Reduced 35.63%	58,270 $8.14 Million
Q3 2017 Oct 03, 2017	BUY	$129.47 - $135.38 $11.7 Million - $12.3 Million	90,520	90,520 $11.8 Million

Others Institutions Holding JNJ

# of Institutions

4,548

Shares Held

1.72B

Call Options Held

16.8M

Put Options Held

13.9M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centre Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Centre Asset Management, LLC with notifications on news.

Account

Centre Asset Management, LLC Johnson & Johnson Transaction History